Current and Emerging Management Strategies for Vitiligo
Vitiligo is an autoimmune skin disease that affects >3 million individuals in the US and around 74 million worldwide. In addition to physical symptoms such as itch, it can be particularly cosmetically concerning and psychologically distressing. It mainly affects young individuals, where it is estimated that 50% of cases have onset before the age of 20. Importantly, it is associated with other a …
Vitiligo is an autoimmune skin disease that affects >3 million individuals in the US and around 74 million worldwide. In addition to physical symptoms such as itch, it can be particularly cosmetically concerning and psychologically distressing. It mainly affects young individuals, where it is estimated that 50% of cases have onset before the age of 20. Importantly, it is associated with other a … Continue reading "Current and Emerging Management Strategies for Vitiligo"
What are the unique indications for permanent hair removal in gender minorities?
For transgender women and other gender minority people seeking a more feminine and/or androgynous appearance, the use of feminizing hormone therapy (e.g. estrogen + finasteride/spironolactone) does not fully eliminate facial and body hair.1 Many transwomen indicate the face as the most important body part for gend … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. John Harris, Vice-Chair of Dermatology and Director of the Vitiligo Clinic and Research Center at UMass Medical School in Worcester, Massachusetts, on new vitiligo treatments in the horizon. Watch as he shares recent discoveries that have influenced the way that we diagnose and manage pat … 
Acne vulgaris is one of the most common reasons for visiting the dermatologist. Topical retinoids are a mainstay of and considered first-line treatment, but patients often face issues with tolerability, which can impact adherence to therapy. We continue our series, Therapeutic Cheat Sheet, with a closer look at the recently FDA approved trifarotene.
[caption id="attachment_10430" align="alignle … 
We all think about allergic contact dermatitis when a patient presents with a classic well-demarcated distribution of eczematous, pruritic rash. But under what other clinical scenarios should we consider the diagnosis of allergic contact dermatitis? At the 17th Annual ODAC Dermatology, Aesthetic and Surgical Conference, Dr. Jonathan Zippin discussed three different clinical conundrums that should … 